• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Haff is killing the Rheum Vibe

anonymous

Guest
Haff is completely out of touch with his DMs and the Rheum team .no f’ing clue. That wrong ass regin needs to get his head straight. Also you have elicit relationships like in Austin with AA and KR in Houston and it’s ok. Sleep your way to the top is the new Abbvie. Colored folks not allowed. We value no diversity here